Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Publication year range
1.
Sci Rep ; 14(1): 20999, 2024 09 09.
Article in English | MEDLINE | ID: mdl-39251686

ABSTRACT

Skin-resident regulatory T cells (Tregs) play an irreplaceable role in orchestrating cutaneous immune homeostasis and repair, including the promotion of hair regeneration via the Notch signaling ligand Jagged-1 (Jag1). While skin Tregs are indispensable for facilitating tissue repair post-wounding, it remains unknown if Jag1-expressing skin Tregs impact wound healing. Using a tamoxifen inducible Foxp3creERT2Jag1fl/fl model, we show that loss of functional Jag1 in Tregs significantly delays the rate of full-thickness wound closure. Unlike in hair regeneration, skin Tregs do not utilize Jag1 to impact epithelial stem cells during wound healing. Instead, mice with Treg-specific Jag1 ablation exhibit a significant reduction in Ly6G + neutrophil accumulation at the wound site. However, during both homeostasis and wound healing, the loss of Jag1 in Tregs does not impact the overall abundance or activation profile of immune cell targets in the skin, such as CD4+ and CD8+ T cells, or pro-inflammatory macrophages. This collectively suggests that skin Tregs may utilize Jag1-Notch signalling to co-ordinate innate cell recruitment under conditions of injury but not homeostasis. Overall, our study demonstrates the importance of Jag1 expression in Tregs to facilitate adequate wound repair in the skin.


Subject(s)
Jagged-1 Protein , Skin , T-Lymphocytes, Regulatory , Wound Healing , Animals , Jagged-1 Protein/metabolism , Jagged-1 Protein/genetics , Wound Healing/immunology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , Mice , Skin/metabolism , Skin/immunology , Signal Transduction , Receptors, Notch/metabolism
2.
Eur J Immunol ; 51(8): 2086-2092, 2021 08.
Article in English | MEDLINE | ID: mdl-33949684

ABSTRACT

Regulatory T-cells (Tregs) are a subset of T cells generated in the thymus with intrinsic immunosuppressive properties. Phase I clinical trials have shown safety and feasibility of Treg infusion to promote immune tolerance and new studies are ongoing to evaluate their efficacy. During heart transplantation, thymic tissue is routinely discarded providing an attractive source of Tregs. In this study, we developed a GMP-compatible protocol for expanding sorted thymus-derived CD3+ CD4+ CD25+ CD127- (Tregs) as well as CD3+ CD4+ CD25+ CD127- CD45RA+ (RA+ Tregs) cells. We aimed to understand whether thymic RA+ Tregs can be isolated and expanded offering an advantage in terms of stability as it has been previously shown for circulating adult CD45RA+ Tregs. We show that both Tregs and RA+ Tregs could be expanded in large numbers and the presence of rapamycin is essential to inhibit the growth of IFN-γ producing cells. High levels of FOXP3, CTLA4, and CD25 expression, demethylation of the FOXP3 promoter, and high suppressive ability were found with no differences between Tregs and RA+ Tregs. After freezing and thawing, all Treg preparations maintained their suppressive ability, stability, as well as CD25 and FOXP3 expression. The number of thymic Tregs that could be isolated with our protocol, their fold expansion, and functional characteristics allow the clinical application of this cell population to promote tolerance in pediatric heart transplant patients.


Subject(s)
Flow Cytometry/methods , Heart Transplantation , T-Lymphocytes, Regulatory , Child , Child, Preschool , Female , Humans , Infant , Male , Thymus Gland/cytology
3.
Am J Transplant ; 21(4): 1415-1426, 2021 04.
Article in English | MEDLINE | ID: mdl-32483894

ABSTRACT

B cells have been implicated in transplant rejection via antibody-mediated mechanisms and more recently by presenting donor antigens to T cells. We have shown in patients with chronic antibody-mediated rejection that B cells control the indirect T cell alloresponses. To understand more about the role of B cells as antigen-presenting cells for CD4+ T cell with indirect allospecificity, B cells were depleted in C57BL/6 mice, using an anti-CD20 antibody, prior to receiving MHC class I-mismatched (Kd ) skin. The absence of B cells at the time of transplantation prolonged skin graft survival. To study the mechanisms behind this observation, T cells with indirect allospecificity were transferred in mice receiving a Kd skin transplant. T cell proliferation was markedly inhibited in the absence of recipient B cells, suggesting that B cells contribute to indirect pathway sensitization. Furthermore, we have shown that a possible way in which B cells present alloantigens is via acquisition of MHC-peptide complexes. Finally, we demonstrate that the addition of B cell depletion to the transfer of regulatory T cells (Tregs) with indirect alloresponse further prolonged skin graft survival. This study supports an important role for B cells in indirect T cell priming and further emphasizes the advantage of combination therapies in prolonging transplant survival.


Subject(s)
B-Lymphocytes , Extracellular Vesicles , Animals , Graft Rejection/etiology , Humans , Isoantigens , Mice , Mice, Inbred C57BL , Transplantation, Homologous
4.
Sci Rep ; 8(1): 6065, 2018 04 17.
Article in English | MEDLINE | ID: mdl-29666503

ABSTRACT

Regulatory T cells (Treg) are a subpopulation of T cells that maintain tolerance to self and limit other immune responses. They achieve this through different mechanisms including the release of extracellular vesicles (EVs) such as exosomes as shown by us, and others. One of the ways that Treg derived EVs inhibit target cells such as effector T cells is via the transfer of miRNA. Another key target for the immunoregulatory function of Tregs is the dendritic cells (DCs). In this study we demonstrate directly, and for the first time, that miRNAs are transferred from Tregs to DCs via Treg derived EVs. In particular two miRNAs, namely miR-150-5p and miR-142-3p, were increased in DCs following their interaction with Tregs and Treg derived exosomes. One of the consequences for DCs following the acquisition of miRNAs contained in Treg derived EVs was the induction of a tolerogenic phenotype in these cells, with increased IL-10 and decreased IL-6 production being observed following LPS stimulation. Altogether our findings provide data to support the idea that intercellular transfer of miRNAs via EVs may be a novel mechanism by which Tregs regulate DC function and could represent a mechanism to inhibit immune reactions in tissues.


Subject(s)
Dendritic Cells/immunology , Extracellular Vesicles/immunology , MicroRNAs/genetics , T-Lymphocytes, Regulatory/immunology , Animals , Cells, Cultured , Coculture Techniques , Cytokines/immunology , Dendritic Cells/cytology , Dendritic Cells/metabolism , Extracellular Vesicles/genetics , Female , Immune Tolerance , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , MicroRNAs/immunology , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/metabolism , Up-Regulation
5.
Biol Blood Marrow Transplant ; 23(2): 293-299, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27816648

ABSTRACT

Prevention of graft-versus-host disease (GVHD) is paramount for allogeneic hematopoietic stem cell transplantation (HSCT) to treat nonmalignant diseases. We previously reported that allogeneic HSCT for severe aplastic anemia (SAA) using the fludarabine, cyclophosphamide, and alemtuzumab (Campath-1H) (FCC) regimen is associated with a very low risk of GVHD and excellent clinical outcomes. We now report a single-center study of 45 patients with longer follow-up and investigation of lymphocyte recovery. Overall survival (OS) was 93%, and event-free survival (EFS) was 90.7%. Acute and chronic GVHD each occurred in 6 patients (13.3%), and only 1 case was severe. Mixed T cell chimerism was frequent and persisted after cessation of immunosuppression. T cells were extensively depleted, representing only 11.3% of lymphocytes at day 30 and rising to 43.8% by 1 year, but still significantly below normal levels (67.2%; P = .018), and deficiency persisted after immunosuppressive therapy (IST) withdrawal. Depletion of CD4 T cells was particularly profound, causing inversion of the normal CD4:CD8 T cell ratio. T cell subset composition was also abnormal, with memory and effector T cells predominating for at least 6 months after FCC HSCT. Analysis of T cell subset chimerism showed that CD4 T cells were predominantly donor-derived at 1 year, whereas recipient-derived CD8 T cells shaped mixed chimerism with a notable contribution of recipient effector CD8 T cells. The prolonged mixed T cell chimerism after IST withdrawal and low incidence of GVHD indicates the establishment of mutual tolerance, but the low incidence of viral disease suggests maintenance of antiviral immunity. Our study shows that despite the abnormal T cell profile after allogeneic HSCT for SAA using the FCC regimen, this regimen is conducive to an excellent clinical outcome.


Subject(s)
Alemtuzumab/pharmacology , Anemia, Aplastic/therapy , CD8-Positive T-Lymphocytes/immunology , Hematopoietic Stem Cell Transplantation , Transplantation Conditioning , Adolescent , Adult , Cell Survival , Female , Graft Survival , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Retrospective Studies , T-Lymphocyte Subsets/immunology , Transplantation Chimera , Treatment Outcome , Whole-Body Irradiation , Young Adult
6.
Rev. méd. Chile ; 136(6): 763-766, jun. 2008. ilus
Article in Spanish | LILACS | ID: lil-490763

ABSTRACT

Retinoic acid is a widely used drug in the treatment of cystic acné. It has teratogenic effects that depend on the gestational period in which it is used. We report a seven months of female whose mother was exposed to retinoic acid in both pregestational and gestational periods. She had a retardation of psychomotor development and a brain MRI showed frontal atrophy and a malformation of the posterior fossa. We discuss the mechanisms ofthe teratogenic effeets of retinoic acid.


Subject(s)
Female , Humans , Infant , Pregnancy , Abnormalities, Drug-Induced , Abnormalities, Multiple/chemically induced , Craniofacial Abnormalities/chemically induced , Isotretinoin/adverse effects , Keratolytic Agents/adverse effects , Teratogens , Acne Vulgaris/drug therapy , Atrophy/chemically induced , Cranial Fossa, Posterior/abnormalities , Cranial Fossa, Posterior/drug effects , Frontal Lobe/abnormalities , Frontal Lobe/drug effects , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects/chemically induced , Psychomotor Disorders/chemically induced , Tretinoin/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL